MX2021001228A - Composicion para uso en la prevencion y/o tratamiento de la mucosa genitourinaria. - Google Patents

Composicion para uso en la prevencion y/o tratamiento de la mucosa genitourinaria.

Info

Publication number
MX2021001228A
MX2021001228A MX2021001228A MX2021001228A MX2021001228A MX 2021001228 A MX2021001228 A MX 2021001228A MX 2021001228 A MX2021001228 A MX 2021001228A MX 2021001228 A MX2021001228 A MX 2021001228A MX 2021001228 A MX2021001228 A MX 2021001228A
Authority
MX
Mexico
Prior art keywords
composition
prevention
treatment
refers
genitourinary mucosa
Prior art date
Application number
MX2021001228A
Other languages
English (en)
Inventor
Vilaboa Deborah Rodriguez
Original Assignee
Mucosa Innovations S L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mucosa Innovations S L filed Critical Mucosa Innovations S L
Publication of MX2021001228A publication Critical patent/MX2021001228A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Organic Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

La presente invención se refiere a una composición para su uso en la prevención y/o el tratamiento de una condición médica que afecta a la mucosa urogenital. También se refiere al uso de dicha composición para la preparación de un medicamento para la prevención y/o el tratamiento de dicha condición. Además, se refiere a un método para la prevención y/o el tratamiento de dicha condición en el que dicha composición se administra a un sujeto en necesidad del mismo.
MX2021001228A 2018-07-31 2019-07-31 Composicion para uso en la prevencion y/o tratamiento de la mucosa genitourinaria. MX2021001228A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP18382576.9A EP3603626A1 (en) 2018-07-31 2018-07-31 Composition for use in the prevention and/or treatment of the genitourinary mucosa
PCT/EP2019/070588 WO2020025657A1 (en) 2018-07-31 2019-07-31 Composition for use in the prevention and/or treatment of the genitourinary mucosa

Publications (1)

Publication Number Publication Date
MX2021001228A true MX2021001228A (es) 2021-05-12

Family

ID=63244524

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021001228A MX2021001228A (es) 2018-07-31 2019-07-31 Composicion para uso en la prevencion y/o tratamiento de la mucosa genitourinaria.

Country Status (8)

Country Link
US (1) US20210322505A1 (es)
EP (2) EP3603626A1 (es)
JP (1) JP7252317B2 (es)
CN (1) CN112770765B (es)
AU (1) AU2019313547A1 (es)
BR (1) BR112021001873A2 (es)
MX (1) MX2021001228A (es)
WO (1) WO2020025657A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112022017207A2 (pt) * 2020-02-28 2022-10-11 Mucosa Innovations S L Composição para a prevenção e tratamento de disbiose
WO2024079251A1 (en) * 2022-10-12 2024-04-18 Bioactor Bv Non-therapeutic use of a composition comprising oleuropein

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI106923B (fi) 1997-01-03 2001-05-15 Cultor Ltd Finnsugar Bioproduc Trimetyyliglysiinin käyttö kehon limakalvojen hygieniaan ja hoitoon tarkoitetuissa valmisteissa
EP2366395A1 (en) 2000-12-15 2011-09-21 Novo Nordisk Femcare AG Use of an oestrogen in the manufacture of a composition containing oestrogen for the treatment of atrophic vaginitis
ITMI20030195A1 (it) * 2003-02-06 2004-08-07 Bsd Bioscience Dev Snc Di O Mini C E Zucc Formulazioni topiche contenenti principi attivi naturali adatte alla prevenzione e cura dei processi infiammatori delle mucose
CN101405006A (zh) 2006-01-20 2009-04-08 梨树医药公司 治疗萎缩性阴道炎的方法
US20080193489A1 (en) 2007-02-13 2008-08-14 Robert De Armond Personal Lubricant Compositions That Are Free Of Glycerin and Parabens
ES2304103B1 (es) 2007-02-22 2009-08-07 Biocosmetics S.L. Composicion para tratamiento de la xerostomia o boca seca.
JP5930713B2 (ja) * 2009-03-30 2016-06-08 ライオン株式会社 口腔用組成物
IT1405998B1 (it) * 2010-12-09 2014-02-06 Bionest Ltd Gel polifunzionale contro la secchezza vaginale ad effetto diretto e ritardato

Also Published As

Publication number Publication date
EP3829553A1 (en) 2021-06-09
CN112770765B (zh) 2022-12-02
BR112021001873A2 (pt) 2021-05-11
JP7252317B2 (ja) 2023-04-04
WO2020025657A9 (en) 2020-05-22
AU2019313547A1 (en) 2021-02-25
WO2020025657A1 (en) 2020-02-06
EP3603626A1 (en) 2020-02-05
US20210322505A1 (en) 2021-10-21
CN112770765A (zh) 2021-05-07
JP2021533123A (ja) 2021-12-02

Similar Documents

Publication Publication Date Title
MX2022010270A (es) Nuevo enfoque para tratar el cancer mediante el uso de la inmunomodulacion.
MX2019012884A (es) Terapia de combinacion.
EA201992722A1 (ru) N2,n4-дифенилпиримидин-2,4-диаминовое производное, способ его получения и фармацевтическая композиция, содержащая его в качестве активного ингредиента, для профилактики и лечения рака
NZ721500A (en) Use of halogen compounds for the treatment and prevention of heart attack and ischemic injury
MX365366B (es) Formulaciones tópicas y orales que comprenden taurina y magnesio para la prevención y el tratamiento del acné.
MX2019003173A (es) Terapia de combinacion con agonistas de peptido natriuretico tipo c (cnp) de liberacion controlada.
MX2020001164A (es) Composicion para su uso en la prevencion y/o el tratamiento de la mucositis orogastrointestinal inducida por un tratamiento oncologico.
EA033298B1 (ru) Комбинированная лекарственная форма тезофензина и метопролола
PH12016502233A1 (en) (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine
MX2022007285A (es) Compuestos, polimeros, dispositivos y usos de los mismos.
MX2021001228A (es) Composicion para uso en la prevencion y/o tratamiento de la mucosa genitourinaria.
MD20170025A2 (ro) Tratamente terapeutice pe bază de anamorelin
PH12020500096A1 (en) Therapeutic combination of a third generation egfr tyrosine kinase inhibitor and a raf inhibitor
MX2018009662A (es) Metodo y composicion farmaceutica para tratamiento de neurodegeneracion.
MX2021004207A (es) Uso de reboxetina para el tratamiento de narcolepsia.
MX2021003160A (es) Combinaciones de inhibidores de tgfbeta e inhibidores de cdk para el tratamiento de cancer de mama.
PH12019501439A1 (en) Use of lactic acid bacteria to treat or prevent gestational diabetes mellitus
NZ726131A (en) (r)-pirlindole and its pharmaceutically acceptable salts for use in medicine
SG10201809673RA (en) Treatment of androgen deprivation therapy associated symptoms
MX2019000006A (es) Composiciones para el tratamiento de estrias y ulceras de origen isquemico.
MX2022010628A (es) Composicion para la prevencion y tratamiento de la disbiosis.
MX2022004785A (es) Metodos y composiciones para el tratamiento del sindrome de rett.
MX2020001217A (es) Metodos de tratamiento de sintomas de gastroparesia usando velusetrag.
WO2018030881A3 (ko) 맥락막 질환의 치료를 위한 갑상선 호르몬의 용도
SG10201700775YA (en) A Pharmaceutical Composition For Use In The Treatment Or Prevention Of A C5-Related Disease And A Method For Treating Or Preventing A C5-Related Disease